Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 38 studies | 50% ± 23% | |
endothelial cell | 37 studies | 45% ± 23% | |
pericyte | 28 studies | 46% ± 25% | |
smooth muscle cell | 24 studies | 40% ± 19% | |
connective tissue cell | 17 studies | 58% ± 24% | |
capillary endothelial cell | 13 studies | 38% ± 23% | |
myofibroblast cell | 13 studies | 56% ± 25% | |
endothelial cell of vascular tree | 13 studies | 33% ± 10% | |
endothelial cell of artery | 12 studies | 35% ± 23% | |
vein endothelial cell | 11 studies | 41% ± 24% | |
basal cell | 11 studies | 24% ± 9% | |
endothelial cell of lymphatic vessel | 10 studies | 36% ± 19% | |
epithelial cell | 9 studies | 37% ± 23% | |
abnormal cell | 8 studies | 28% ± 17% | |
type I pneumocyte | 7 studies | 33% ± 24% | |
mesothelial cell | 7 studies | 61% ± 23% | |
macrophage | 5 studies | 24% ± 8% | |
adventitial cell | 5 studies | 36% ± 11% | |
adipocyte | 5 studies | 34% ± 31% | |
glomerular endothelial cell | 4 studies | 34% ± 10% | |
progenitor cell | 4 studies | 52% ± 26% | |
type II pneumocyte | 3 studies | 36% ± 23% | |
conventional dendritic cell | 3 studies | 17% ± 1% | |
neural crest cell | 3 studies | 26% ± 5% | |
extravillous trophoblast | 3 studies | 34% ± 19% | |
chondrocyte | 3 studies | 46% ± 26% | |
myoepithelial cell | 3 studies | 46% ± 23% | |
luminal cell of prostate epithelium | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 14267.73 | 180 / 180 | 100% | 185.64 | 429 / 430 |
lung | 100% | 19468.31 | 577 / 578 | 100% | 166.04 | 1150 / 1155 |
breast | 100% | 10824.03 | 459 / 459 | 99% | 158.48 | 1102 / 1118 |
uterus | 100% | 14327.69 | 170 / 170 | 98% | 214.88 | 452 / 459 |
bladder | 100% | 16279.29 | 21 / 21 | 98% | 153.13 | 494 / 504 |
thymus | 100% | 9844.37 | 653 / 653 | 97% | 80.93 | 589 / 605 |
skin | 95% | 19728.12 | 1721 / 1809 | 99% | 211.88 | 469 / 472 |
kidney | 99% | 7665.46 | 88 / 89 | 95% | 113.02 | 858 / 901 |
intestine | 96% | 7818.04 | 931 / 966 | 98% | 120.89 | 515 / 527 |
prostate | 99% | 7103.53 | 243 / 245 | 93% | 51.81 | 465 / 502 |
esophagus | 92% | 6638.84 | 1323 / 1445 | 96% | 134.92 | 175 / 183 |
stomach | 82% | 5821.69 | 293 / 359 | 98% | 118.11 | 280 / 286 |
adrenal gland | 100% | 9816.60 | 258 / 258 | 73% | 70.30 | 169 / 230 |
pancreas | 44% | 1600.18 | 144 / 328 | 97% | 196.88 | 172 / 178 |
liver | 55% | 2347.45 | 125 / 226 | 63% | 49.14 | 257 / 406 |
adipose | 100% | 15709.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 103.68 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 95.13 | 1 / 1 |
blood vessel | 99% | 12490.86 | 1327 / 1335 | 0% | 0 | 0 / 0 |
spleen | 98% | 5459.07 | 236 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 104.41 | 44 / 45 |
heart | 96% | 9442.72 | 823 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 72% | 41.29 | 21 / 29 |
brain | 24% | 1624.69 | 639 / 2642 | 40% | 38.03 | 279 / 705 |
peripheral blood | 39% | 2305.54 | 365 / 929 | 0% | 0 | 0 / 0 |
muscle | 17% | 508.43 | 137 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006986 | Biological process | response to unfolded protein |
GO_0030199 | Biological process | collagen fibril organization |
GO_0003433 | Biological process | chondrocyte development involved in endochondral bone morphogenesis |
GO_0032964 | Biological process | collagen biosynthetic process |
GO_0010951 | Biological process | negative regulation of endopeptidase activity |
GO_0051604 | Biological process | protein maturation |
GO_0045121 | Cellular component | membrane raft |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0005518 | Molecular function | collagen binding |
GO_0005515 | Molecular function | protein binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | SERPINH1 |
Protein name | Serpin H1 (Collagen-binding protein) Serpin family H member 1 Serpin H1 (47 kDa heat shock protein) (Arsenic-transactivated protein 3) (AsTP3) (Cell proliferation-inducing gene 14 protein) (Collagen-binding protein) (Colligin) (Rheumatoid arthritis-related antigen RA-A47) |
Synonyms | SERPINH2 CBP2 CBP1 PIG14 HSP47 |
Description | FUNCTION: Binds specifically to collagen. Could be involved as a chaperone in the biosynthetic pathway of collagen. FUNCTION: Binds specifically to collagen. Could be involved as a chaperone in the biosynthetic pathway of collagen. . |
Accessions | ENST00000526638.1 E9PLA6 ENST00000532356.5 ENST00000525611.5 ENST00000649490.1 ENST00000530284.5 ENST00000528990.1 P50454 E9PKH2 E9PIG2 E9PR70 ENST00000528760.1 E9PMI5 E9PRS3 ENST00000525492.5 ENST00000533449.6 ENST00000524558.5 ENST00000529643.1 E9PJH8 H0YEP8 E9PNX1 ENST00000358171.8 ENST00000526242.1 ENST00000533603.5 ENST00000526397.5 E9PPV6 ENST00000525876.1 E9PK86 E9PQ34 |